China’s biotechnology merger and acquisition (M&A) transactions have almost doubled this year, with interest perking up among investors amid a…
Read More »Drugs
Chinese tech giant Baidu is in talks with investors to raise up to US$2 billion over three years for a…
Read More »The dietary supplement producer, established in 2004, spent 2 billion yuan (US$294 million) to build a factory this year in…
Read More »Hutchison China MediTech (Chi-Med), whose stock has surged 70 per cent in London over the past six months, expects to…
Read More »Novoheart Holdings, the inventor of artificial “mini-hearts” co-founded by a Hong Kong scientist, is expanding its research and manufacturing budget…
Read More »A new study has pinpointed brain neurons that separate the sensation of fullness from nausea in obesity drugs, paving the…
Read More »Research on MDMA’s use in psychotherapy have led to new variants developed by MedUni Vienna that could offer similar benefits…
Read More »Researchers have found that studying proteins at body temperature reveals new drug binding sites, potentially revolutionizing drug design by providing…
Read More »Ubiquitin plays a crucial role in cellular processes by regulating protein stability, but USP28 inhibitors, aimed at inhibiting cancer growth,…
Read More »A recent study shows that ruxolitinib, a drug targeting interferon-gamma (IFN-gamma), effectively alleviates symptoms of the rare autoimmune polyendocrine syndrome…
Read More »